 Judith Gault
Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 4 | 2025 | 222 | 1.740 |
Why?
| | Schizophrenia | 6 | 2025 | 489 | 1.310 |
Why?
| | Psychotic Disorders | 2 | 2025 | 199 | 1.250 |
Why?
| | Microtubule-Associated Proteins | 3 | 2009 | 197 | 0.690 |
Why?
| | Essential Tremor | 1 | 2020 | 24 | 0.600 |
Why?
| | Proto-Oncogene Proteins | 3 | 2009 | 627 | 0.590 |
Why?
| | Evoked Potentials, Auditory | 2 | 2020 | 181 | 0.580 |
Why?
| | Thalamus | 1 | 2020 | 132 | 0.550 |
Why?
| | Corpus Striatum | 1 | 2020 | 181 | 0.540 |
Why?
| | Hemangioma, Cavernous, Central Nervous System | 4 | 2006 | 8 | 0.540 |
Why?
| | Intracranial Arteriovenous Malformations | 2 | 2009 | 53 | 0.330 |
Why?
| | Receptors, Nicotinic | 4 | 2009 | 328 | 0.300 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2009 | 187 | 0.280 |
Why?
| | Point Mutation | 1 | 2009 | 245 | 0.270 |
Why?
| | Cerebrovascular Disorders | 2 | 2006 | 106 | 0.250 |
Why?
| | Polymorphism, Single-Stranded Conformational | 2 | 2003 | 26 | 0.210 |
Why?
| | Germ-Line Mutation | 1 | 2005 | 180 | 0.200 |
Why?
| | Gene Duplication | 1 | 2003 | 67 | 0.200 |
Why?
| | KRIT1 Protein | 3 | 2009 | 4 | 0.190 |
Why?
| | Genetic Linkage | 1 | 2003 | 273 | 0.190 |
Why?
| | Endothelial Cells | 1 | 2009 | 886 | 0.190 |
Why?
| | Membrane Proteins | 1 | 2009 | 1171 | 0.190 |
Why?
| | Chromosomes, Human, Pair 15 | 4 | 2009 | 50 | 0.180 |
Why?
| | Tic Disorders | 1 | 2021 | 10 | 0.170 |
Why?
| | Fluvoxamine | 1 | 2021 | 18 | 0.170 |
Why?
| | Serotonin Antagonists | 1 | 2021 | 32 | 0.170 |
Why?
| | Risperidone | 1 | 2021 | 30 | 0.170 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2021 | 46 | 0.160 |
Why?
| | Obsessive-Compulsive Disorder | 1 | 2021 | 61 | 0.160 |
Why?
| | DNA Mutational Analysis | 4 | 2009 | 414 | 0.150 |
Why?
| | Hemorrhage | 1 | 2005 | 832 | 0.150 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2006 | 2223 | 0.140 |
Why?
| | Parkinson Disease | 1 | 2025 | 613 | 0.140 |
Why?
| | Neural Pathways | 1 | 2020 | 320 | 0.130 |
Why?
| | Autistic Disorder | 1 | 2021 | 226 | 0.130 |
Why?
| | Risk Assessment | 1 | 2006 | 3784 | 0.120 |
Why?
| | Brain | 3 | 2006 | 3009 | 0.120 |
Why?
| | Genotype | 4 | 2009 | 1875 | 0.120 |
Why?
| | Middle Aged | 5 | 2025 | 36821 | 0.110 |
Why?
| | Base Sequence | 3 | 2009 | 2175 | 0.090 |
Why?
| | Exons | 2 | 2005 | 365 | 0.090 |
Why?
| | Sequence Analysis, DNA | 3 | 2005 | 780 | 0.090 |
Why?
| | Humans | 16 | 2025 | 147293 | 0.090 |
Why?
| | Surveys and Questionnaires | 1 | 2025 | 6164 | 0.090 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 4 | 2009 | 94 | 0.090 |
Why?
| | Male | 8 | 2025 | 73950 | 0.090 |
Why?
| | Female | 7 | 2025 | 80076 | 0.080 |
Why?
| | Molecular Sequence Data | 2 | 2005 | 2886 | 0.080 |
Why?
| | Sequence Deletion | 1 | 2009 | 192 | 0.070 |
Why?
| | Adult | 6 | 2025 | 41405 | 0.070 |
Why?
| | Promoter Regions, Genetic | 2 | 2003 | 1253 | 0.070 |
Why?
| | Gene Expression | 2 | 2004 | 1481 | 0.070 |
Why?
| | Gene Frequency | 1 | 2009 | 498 | 0.070 |
Why?
| | Genetic Variation | 2 | 2003 | 995 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 980 | 0.060 |
Why?
| | Central Nervous System Cysts | 1 | 2006 | 13 | 0.060 |
Why?
| | Dementia, Vascular | 1 | 2006 | 21 | 0.060 |
Why?
| | Genetic Markers | 2 | 2005 | 338 | 0.060 |
Why?
| | Cerebral Arteries | 1 | 2006 | 59 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 3 | 2009 | 3980 | 0.060 |
Why?
| | Alleles | 2 | 2009 | 909 | 0.060 |
Why?
| | Heterozygote | 1 | 2006 | 317 | 0.060 |
Why?
| | Calcinosis | 1 | 2006 | 234 | 0.050 |
Why?
| | Spinal Cord Neoplasms | 1 | 2004 | 41 | 0.050 |
Why?
| | Brain Neoplasms | 2 | 2004 | 1338 | 0.050 |
Why?
| | Central Nervous System Vascular Malformations | 1 | 2004 | 27 | 0.050 |
Why?
| | Genetic Testing | 1 | 2006 | 493 | 0.050 |
Why?
| | Gene Deletion | 1 | 2005 | 392 | 0.050 |
Why?
| | Hemangioma, Cavernous | 1 | 2003 | 13 | 0.050 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2005 | 593 | 0.050 |
Why?
| | Introns | 1 | 2003 | 260 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2004 | 376 | 0.050 |
Why?
| | Neovascularization, Pathologic | 1 | 2004 | 287 | 0.050 |
Why?
| | Central Nervous System Neoplasms | 1 | 2004 | 178 | 0.050 |
Why?
| | Family | 1 | 2006 | 690 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2009 | 2458 | 0.040 |
Why?
| | Neural Inhibition | 1 | 2002 | 180 | 0.040 |
Why?
| | Amino Acid Sequence | 1 | 2005 | 2134 | 0.040 |
Why?
| | Aged | 2 | 2020 | 26514 | 0.040 |
Why?
| | Linkage Disequilibrium | 1 | 2001 | 259 | 0.040 |
Why?
| | Prevalence | 1 | 2006 | 2889 | 0.040 |
Why?
| | RNA | 1 | 2005 | 916 | 0.030 |
Why?
| | Mutation | 2 | 2006 | 4130 | 0.030 |
Why?
| | Colorado | 1 | 2006 | 4591 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1672 | 0.030 |
Why?
| | Stroke | 1 | 2005 | 1287 | 0.030 |
Why?
| | Patient Care Team | 1 | 2021 | 712 | 0.030 |
Why?
| | Child, Preschool | 1 | 2009 | 12016 | 0.030 |
Why?
| | Signal Transduction | 2 | 2004 | 5272 | 0.020 |
Why?
| | Polymorphism, Genetic | 2 | 2009 | 615 | 0.020 |
Why?
| | Risk Factors | 1 | 2006 | 11017 | 0.020 |
Why?
| | Adolescent | 2 | 2009 | 22825 | 0.020 |
Why?
| | Blotting, Southern | 1 | 2009 | 85 | 0.020 |
Why?
| | Gene Dosage | 1 | 2009 | 145 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2009 | 330 | 0.020 |
Why?
| | Vasculitis, Central Nervous System | 1 | 2006 | 16 | 0.020 |
Why?
| | Headache Disorders | 1 | 2006 | 19 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2006 | 125 | 0.010 |
Why?
| | Fatal Outcome | 1 | 2006 | 306 | 0.010 |
Why?
| | Intracranial Hemorrhages | 1 | 2006 | 107 | 0.010 |
Why?
| | Patient Selection | 1 | 2009 | 746 | 0.010 |
Why?
| | Angiopoietins | 1 | 2004 | 12 | 0.010 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2004 | 100 | 0.010 |
Why?
| | Telangiectasia, Hereditary Hemorrhagic | 1 | 2004 | 14 | 0.010 |
Why?
| | Hepatocyte Growth Factor | 1 | 2004 | 33 | 0.010 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2004 | 85 | 0.010 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2004 | 94 | 0.010 |
Why?
| | Genetic Counseling | 1 | 2004 | 82 | 0.010 |
Why?
| | Auditory Perceptual Disorders | 1 | 2002 | 8 | 0.010 |
Why?
| | Anti-Inflammatory Agents | 1 | 2006 | 481 | 0.010 |
Why?
| | Corpus Callosum | 1 | 2003 | 78 | 0.010 |
Why?
| | Temporal Arteries | 1 | 2003 | 45 | 0.010 |
Why?
| | Temporal Lobe | 1 | 2003 | 113 | 0.010 |
Why?
| | Schizophrenic Psychology | 1 | 2002 | 102 | 0.010 |
Why?
| | Frontal Lobe | 1 | 2003 | 161 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2002 | 512 | 0.010 |
Why?
| | Genetic Therapy | 1 | 2004 | 317 | 0.010 |
Why?
| | Anticoagulants | 1 | 2006 | 751 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2004 | 552 | 0.010 |
Why?
| | Transforming Growth Factor beta | 1 | 2004 | 475 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2003 | 751 | 0.010 |
Why?
| | Lymphocytes | 1 | 2002 | 378 | 0.010 |
Why?
| | Down-Regulation | 1 | 2003 | 618 | 0.010 |
Why?
| | Up-Regulation | 1 | 2003 | 848 | 0.010 |
Why?
| | Pedigree | 1 | 2001 | 522 | 0.010 |
Why?
| | Disease Progression | 1 | 2006 | 2890 | 0.010 |
Why?
| | Phenotype | 1 | 2004 | 3216 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2003 | 2812 | 0.010 |
Why?
| | Child | 1 | 2003 | 22979 | 0.000 |
Why?
|
|
Gault's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|